While no device has been proven to prevent epilepsy-related mortality (including SUDEP), Twelve 28 Gives is here to help those affected and those caregivers seeking out prediction devices. Intervention is believed to reduce the risks; however, anyone with seizure disorders should always consult their medical professionals.
Disclosure: The Embrace2 Watch is a consumer product approved by the FDA. Twelve 28 Gives strongly advises communication with the manufacturer of this product as well as consultation with your medical provider. The Embrace2 Watch requires a prescription from your neurologist.
Twelves 28 Gives is not a manufacturer, distributor, seller, representative, or broker of the Embrace2 Watch shown on this website. Twelve 28 Gives only offers introductory information about the potential of this device and does not accept responsibility for the consequences of the actual use of the Embrace2 Watch listed on this website.
Embrace2 Watch by Empatica
Embrace2 is a wristwatch worn device that is designed to detect and alert for tonic-clonic (convulsive) seizures after 20 seconds, and to monitor physical activity and rest. Embrace2 transmits data to a paired smartphone via a Bluetooth connection, and has the ability to alert others via a text message and phone call when certain seizure types occur The system requires the person wearing the watch to have a compatible smartphone, which they must keep within approximately 25 feet.
The cost for this system includes a one-time purchase of the watch, as well as a monthly subscription fee. Embrace2 received FDA approval in 2018 for its ability to alert to convulsive seizures. If you are applying for funding for a child user, please note that the child must have their own smartphone with them at all times, and the caregiver must have their own phone to receive the alert. Please see company information below.
